Filing Details
- Accession Number:
- 0001161697-23-000173
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-22 16:45:42
- Reporting Period:
- 2023-03-20
- Accepted Time:
- 2023-03-22 16:45:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1369568 | Catalyst Pharmaceuticals Inc. | CPRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1763511 | Brian Elsbernd | 355 Alhambra Circle Suite 801 Coral Gables FL 33134 | Chief Compliance/Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2023-03-20 | 50,000 | $1.13 | 188,076 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2023-03-20 | 50,000 | $16.07 | 138,076 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options to Purchase Common Stock | Disposition | 2023-03-20 | 50,000 | $0.00 | 50,000 | $1.13 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 860,334 | 2024-01-03 | No | 4 | M | Direct |
Footnotes
- Mr. Elsbernd sold the shares in the open market for personal reasons and not as a result of a disagreement with the Company. Mr. Elsbernd remains an executive officer of the Company.
- Represents the weighted average price for the shares sold. Shares were sold in various lots ranging from $16.01 to $16.23 per share.
- Options vested in three annual tranches beginning on 1/3/2018.
Billionaire Hedge Funds
